Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

Slides:

Advertisements

Similar presentations

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.

Advertisements

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

Volume 386, Issue 10006, Pages (November 2015)

Clinical value of post–percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis Goran Rimac, MD, William.

The Epidemic of the 20th Century: Coronary Heart Disease

Does Stenosis Severity of Native Vessels Influence Bypass Graft Patency? A Prospective Fractional Flow Reserve–Guided Study Cornelis J. Botman, MD, Jacques.

Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions William F Fearon, MD, Alan C Yeung, MD, David P Lee, MD, Paul.

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

The “occasional open heart surgeon” revisited

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation Hany S. Abed, BPharm, MBBS, PhD,

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Risk of stroke with percutaneous coronary intervention compared with on-pump and off- pump coronary artery bypass graft surgery: Evidence from a comprehensive.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice Manesh R.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Impact of 64-Slice Multidetector Computed Tomography on Other Diagnostic Studies for Coronary Artery Disease Alex J. Auseon, DO, Sunil S. Advani, MD,

The Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease Ronny Alcalai, MD, Nicola Viola, MD, Morris Mosseri,

The present day potential role of fractional flow reserve–guided coronary artery bypass graft surgery Filip Casselman, MD, PhD, FETCS, Johan Van der.

The Epidemic of the 20th Century: Coronary Heart Disease

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery Jeremy J. Pereira, MB, Krzysztof Balaban, MD,

Does Stenosis Severity of Native Vessels Influence Bypass Graft Patency? A Prospective Fractional Flow Reserve–Guided Study Cornelis J. Botman, MD, Jacques.

Value of Magnetic Resonance Imaging, Angiography, and Fractional Flow Reserve to Evaluate the Left Main Coronary Artery After Direct Surgical Angioplasty

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Right internal thoracic artery or saphenous vein grafting

Gout in African Americans

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Evaluation of the Potential Living Kidney Donor

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results Ho Young.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

To bypass or stent? The changing rules of an advancing game

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Supportive care for patients with renal disease: Time for action

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Apples remain apples NO matter what

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Exercise as a Therapeutic Intervention in Patients with Stable Ischemic Heart Disease: An Underfilled Prescription William E. Boden, MD, Barry Franklin,

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Edward Y. Chan, MD, Michael J. Reardon, MD

Presentation transcript:

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease Frederik M. Zimmermann, MD, Bernard De Bruyne, MD, PhD, Nico H.J. Pijls, MD, PhD, Manisha Desai, PhD, Keith G. Oldroyd, MD, Seung-Jung Park, MD, PhD, Michael J. Reardon, MD, Olaf Wendler, MD, PhD, Joseph Woo, MD, Alan C. Yeung, MD, William F. Fearon, MD American Heart Journal Volume 170, Issue 4, Pages 619-626.e2 (October 2015) DOI: 10.1016/j.ahj.2015.06.024 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure FAME 3 flowchart. American Heart Journal 2015 170, 619-626.e2DOI: (10.1016/j.ahj.2015.06.024) Copyright © 2015 Elsevier Inc. Terms and Conditions